Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02625181 · ClinicalTrials.gov registry record · NA
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 27,034
- Enrollment target
NCT02625181: Completed NA study, sponsored by Vanderbilt University.
NCT02625181 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 27,034 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1827% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02625181, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 27,034 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how automated recommendations are best presented to optimize the adherence to guidelines on prophylaxis for nausea and vomiting after surgery.
Primary Outcome
PONV guideline adherence: percentage of patients who received the exact number of prophylactic interventions for PONV that were recommended by the decision support.
Interventions
- DEVICE Anesthesia Information Management System (AIMS)
- PROCEDURE Automated recommendation at the start of the case
- PROCEDURE Automated notification at the start of surgery
- PROCEDURE Preoperative recommendations: by email
- PROCEDURE Automated notification at the end of surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27,034 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-11-30 |
| Phase | NA |
What the finished NCT02625181 record still lists
NCT02625181 is an interventional study that assigns participants to a tested intervention. Its 27,034 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1827% higher).
The record links to 0 conditions, and to 5 interventions - of which Anesthesia Information Management System (AIMS) is the first listed.
NCT02625181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02625181 about?
NCT02625181 is a clinical study titled "Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis". The purpose of this study is to determine how automated recommendations are best presented to optimize the adherence to guidelines on prophylaxis for nausea and vomiting after surgery.
What is the current status of trial NCT02625181?
This trial is currently completed. It is a NA study. The enrollment target is 27,034 participants. The study started on 2016-07. Estimated completion is 2017-11-30.
What interventions are being tested in trial NCT02625181?
The interventions under investigation include: Anesthesia Information Management System (AIMS) (DEVICE), Automated recommendation at the start of the case (PROCEDURE), Automated notification at the start of surgery (PROCEDURE), Preoperative recommendations: by email (PROCEDURE), Automated notification at the end of surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02625181?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02625181's enrollment target sits among peer trials
27,034 9th of 2000 higher than 1,992 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT04494945 · 27,500 participants · NA
Identifying and Caring for Individuals With Inherited Cancer Syndrome
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia